Exane Asset Management - Q2 2020 holdings

$97 Billion is the total value of Exane Asset Management's 16 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 100.0% .

 Value Shares↓ Weighting
ATVI SellACTIVISION BLIZZARD INC COMstock$15,231,157,000
+18.7%
200,674
-7.0%
15.69%
-37.3%
TMUS BuyT-MOBILE US INC COMstock$12,946,991,000
+397.5%
124,311
+300.8%
13.34%
+162.8%
MSFT SellMICROSOFT CORP COMstock$11,570,765,000
+16.5%
56,856
-9.7%
11.92%
-38.5%
OMC NewOMNICOM GROUP INC COMstock$11,458,902,000209,870
+100.0%
11.81%
BABA NewALIBABA GROUP HLDG LTD SPONSORED ADSstock$8,483,050,00039,328
+100.0%
8.74%
UBS SellUBS GROUP AG SHSstock$7,159,534,000
-35.7%
621,806
-47.7%
7.38%
-66.1%
WMT NewWALMART INC COMstock$6,728,761,00056,176
+100.0%
6.93%
NFLX BuyNETFLIX INC COMstock$5,332,159,000
+22.0%
11,718
+0.6%
5.49%
-35.6%
DOX NewAMDOCS LTD SHSstock$5,073,496,00083,336
+100.0%
5.23%
COST NewCOSTCO WHSL CORP NEW COMstock$4,010,862,00013,228
+100.0%
4.13%
DG NewDOLLAR GEN CORP NEW COMstock$2,796,687,00014,680
+100.0%
2.88%
DB NewDEUTSCHE BANK A G NAMEN AKTstock$2,252,981,000362,436
+100.0%
2.32%
CHWY NewCHEWY INC CL Astock$1,487,149,00033,277
+100.0%
1.53%
TAK  TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADSstock$951,940,000
+18.1%
53,0920.0%0.98%
-37.6%
AMGN  AMGEN INC COMstock$831,642,000
+16.3%
3,5260.0%0.86%
-38.5%
CTMX  CYTOMX THERAPEUTICS INC COMstock$732,007,000
+8.6%
87,8760.0%0.75%
-42.7%
BMY ExitBRISTOL-MYERS SQUIBB CO COMstock$0-12,011
-100.0%
-1.31%
TGE ExitTALLGRASS ENERGY LP CLASS A SHSstock$0-169,129
-100.0%
-5.43%
LIN ExitLINDE PLC SHSstock$0-26,870
-100.0%
-9.23%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-07-27
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
UBS GROUP AG SHS25Q1 202331.8%
T-MOBILE US INC COM25Q3 202323.9%
GOLDMAN SACHS GROUP INC COM16Q3 202314.3%
BRISTOL-MYERS SQUIBB CO COM15Q1 20209.9%
CITIGROUP INC COM NEW15Q4 202218.8%
GILEAD SCIENCES INC COM15Q2 20198.9%
DBV TECHNOLOGIES S A SPONSORED ADR13Q2 20191.7%
CYTOMX THERAPEUTICS INC COM13Q4 20201.3%
MICROSOFT CORP COM12Q4 202219.4%
TIM PARTICIPACOES S A SPONSORED ADR12Q3 201912.2%

View Exane Asset Management's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-04-23
13F-HR2024-01-24
13F-HR2023-10-20
13F-HR2023-07-17
13F-HR/A2023-05-11
13F-HR2023-04-25
13F-HR2023-01-17
13F-HR2022-10-24
13F-HR2022-07-15
13F-HR2022-04-21

View Exane Asset Management's complete filings history.

Compare quarters

Export Exane Asset Management's holdings